GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » EirGenix Inc (ROCO:6589) » Definitions » Beginning Cash Position

EirGenix (ROCO:6589) Beginning Cash Position : NT$4,848 Mil (As of Jun. 2024)


View and export this data going back to 2016. Start your Free Trial

What is EirGenix Beginning Cash Position?

EirGenix's Beginning Cash Position for the quarter that ended in Jun. 2024 was NT$4,848 Mil.

EirGenix's quarterly Beginning Cash Position increased from Dec. 2023 (NT$2,865 Mil) to Mar. 2024 (NT$5,053 Mil) but then declined from Mar. 2024 (NT$5,053 Mil) to Jun. 2024 (NT$4,848 Mil).

EirGenix's annual Beginning Cash Position increased from Dec. 2021 (NT$908 Mil) to Dec. 2022 (NT$6,625 Mil) but then declined from Dec. 2022 (NT$6,625 Mil) to Dec. 2023 (NT$6,127 Mil).


EirGenix Beginning Cash Position Historical Data

The historical data trend for EirGenix's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

EirGenix Beginning Cash Position Chart

EirGenix Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Beginning Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 872.75 292.33 908.35 6,625.38 6,126.89

EirGenix Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5,610.35 4,194.08 2,864.97 5,053.18 4,847.88

EirGenix Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.


EirGenix Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of EirGenix's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.


EirGenix Business Description

Traded in Other Exchanges
N/A
Address
No. 101, Lane 169, Kangning Street, Xizhi District, New Taipei, TWN, 22180
EirGenix Inc is engaged in biosimilar and new drug research and development as well as biopharmaceutical contract development and manufacturing services, including cell line construction platforms, process development platforms, analytical science and protein characterisation, as well as PIC/S facilities to provide clinical trial drug production. Its services include Cell Line Development, Process Development, Analytical Science and Quality Control, cGMP manufacturing-mammalian system, cGMP manufacturing-microbial system, and Antibody Drug Conjugate.

EirGenix Headlines

No Headlines